4.6 Letter

Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies

Journal

BRITISH JOURNAL OF HAEMATOLOGY
Volume 192, Issue 6, Pages 1100-1105

Publisher

WILEY
DOI: 10.1111/bjh.17266

Keywords

protracted COVID-19; B-cell depletion; rituximab; anti-CD20; neutralising antibodies

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available